Meningo encephalitis with Epstein-Barr virus in an immunocompetent adult patient: case report [PDF]
Romanian Journal of Infectious Diseases, 2023 Epstein-Barr virus is a rare ethology of the neurological infections, expressed as encephalitis, aseptic meningitis, Guillain-Barre syndrome or acute demyelinating encephalomyelitis.
Sabina-Lucia Ganea +4 more
doaj +1 more source
Epstein–Barr Virus Infection in Cancer
Cancers, 2023 EBV was the first human oncogenic virus identified [...]
Lucia Mundo +2 more
openaire +3 more sources
Patch formation driven by stochastic effects of interaction between viruses and defective interfering particles [PDF]
PLoS Comput Biol 19(10), 2023, 2023 Defective interfering particles (DIPs) are virus-like particles that occur naturally during virus infections. These particles are defective, lacking essential genetic materials for replication, but they can interact with the wild-type virus and potentially be used as therapeutic agents.
arxiv +1 more source
The immunology of Epstein–Barr virus infection [PDF]
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2001 Epstein–Barr virus is a classic example of a persistent human virus that has caught the imagination of immunologists, virologists and oncologists because of the juxtaposition of a number of important properties. First, the ability of the virus to immortalize B lymphocytesin vitrohas provided an antigen presenting cell in which all the latent antigens ...
Moss, Denis J. +4 more
openaire +4 more sources
Stochastic failure of cell infection post viral entry: Implications for infection outcomes and antiviral therapy [PDF]
Sci. Rep. 13, 17243 (2023), 2022 A virus infection can be initiated with very few or even a single infectious virion, and as such can become extinct, i.e. stochastically fail to take hold or spread significantly. There are many ways that a fully competent infectious virion, having successfully entered a cell, can fail to cause a productive infection, i.e.
arxiv +1 more source
Animal models of Epstein Barr virus infection [PDF]
Journal of Immunological Methods, 2014 Epstein Barr virus (EBV) was the first human tumor virus to be identified. Despite 50years of research on this oncogenic virus, no therapeutic or prophylactic vaccine is available against this pathogen. In part, the development of such a vaccine is hampered by the lack of in vivo models for EBV infection and immune control.
Chatterjee Bithi +2 more
openaire +6 more sources
Epstein–Barr virus in the multiple sclerosis brain: a controversial issue—report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria [PDF]
, 2011 Recent epidemiological and immunological studies provide evidence for an association between Epstein–Barr virus infection and multiple sclerosis, suggesting a role of Epstein–Barr virus infection in disease induction and pathogenesis.
Ascherio +92 more
core +2 more sources
Virological aspects of Epstein-Barr virus infections. [PDF]
, 2005 Epstein-Barr virus (EBV) is usually maintained in an asymptomatic and latent form by the host immune system, and primarily by EBV-specific cytotoxic T cells (CTLs).
Kimura, Hiroshi +2 more
core +1 more source
Epstein-Barr Virus Encephalitis: A Case Report [PDF]
, 2015 How to Cite This Article: Hashemian S, Ashrafzadeh F, Akhondian J, Beiraghi Toosi M. Epstein-Barr Virus Encephalitis: A Case Report. Iran J Child Neurol. 2015 Winter;9(1):107-110.
AKHONDIAN, Javad +3 more
core +2 more sources
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy [PDF]
, 1984 Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts ...
Atchison, RW +12 more
core +1 more source